These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 17932968)

  • 41. The genetic architecture of inflammatory bowel disease: past, present and future.
    Cleynen I; Vermeire S
    Curr Opin Gastroenterol; 2015 Nov; 31(6):456-63. PubMed ID: 26444824
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Classification of inflammatory bowel disease: the old and the new.
    Vermeire S; Van Assche G; Rutgeerts P
    Curr Opin Gastroenterol; 2012 Jul; 28(4):321-6. PubMed ID: 22647554
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Scoring systems in inflammatory bowel disease.
    Sehgal R; Koltun WA
    Expert Rev Gastroenterol Hepatol; 2010 Aug; 4(4):513-21. PubMed ID: 20678023
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Noninvasive Testing for Mucosal Inflammation in Inflammatory Bowel Disease.
    Iborra M; Beltrán B; Nos P
    Gastrointest Endosc Clin N Am; 2016 Oct; 26(4):641-56. PubMed ID: 27633593
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Hematologic aspects of inflammatory bowel diseases].
    Udvardy M; Altorjay I; Palatka K
    Orv Hetil; 2001 Apr; 142(17):883-6. PubMed ID: 11373889
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Contribution of the IL-17/IL-23 axis to the pathogenesis of inflammatory bowel disease.
    Cătană CS; Berindan Neagoe I; Cozma V; Magdaş C; Tăbăran F; Dumitraşcu DL
    World J Gastroenterol; 2015 May; 21(19):5823-30. PubMed ID: 26019446
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Diagnostics of inflammatory bowel disease.
    Nikolaus S; Schreiber S
    Gastroenterology; 2007 Nov; 133(5):1670-89. PubMed ID: 17983810
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inflammatory bowel diseases: from pathogenesis to laboratory testing.
    Basso D; Zambon CF; Plebani M
    Clin Chem Lab Med; 2014 Apr; 52(4):471-81. PubMed ID: 24108210
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Monitoring inflammatory bowel disease activity: clinical activity is judged to be more relevant than endoscopic severity or biomarkers.
    Schoepfer AM; Vavricka S; Zahnd-Straumann N; Straumann A; Beglinger C
    J Crohns Colitis; 2012 May; 6(4):412-8. PubMed ID: 22398068
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Why are genetic studies important in IBD?
    Peña AS
    Inflamm Bowel Dis; 2008 Oct; 14 Suppl 2():S79-80. PubMed ID: 18816776
    [No Abstract]   [Full Text] [Related]  

  • 51. MicroRNAs in inflammatory bowel diseases: paradoxes and possibilities.
    Whiteoak SR; Felwick R; Sanchez-Elsner T; Fraser Cummings JR
    Inflamm Bowel Dis; 2015 May; 21(5):1160-5. PubMed ID: 25844960
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Human Blood and Mucosal Regulatory T Cells Express Activation Markers and Inhibitory Receptors in Inflammatory Bowel Disease.
    Lord JD; Shows DM; Chen J; Thirlby RC
    PLoS One; 2015; 10(8):e0136485. PubMed ID: 26305224
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Use of serologic markers as a screening tool in inflammatory bowel disease compared with elevated erythrocyte sedimentation rate and anemia.
    Sabery N; Bass D
    Pediatrics; 2007 Jan; 119(1):e193-9. PubMed ID: 17158948
    [TBL] [Abstract][Full Text] [Related]  

  • 54. (Auto)antibodies in inflammatory bowel diseases.
    Vermeire S; Vermeulen N; Van Assche G; Bossuyt X; Rutgeerts P
    Gastroenterol Clin North Am; 2008 Jun; 37(2):429-38, vii. PubMed ID: 18499029
    [TBL] [Abstract][Full Text] [Related]  

  • 55. An update on diagnostic and prognostic biomarkers in inflammatory bowel disease.
    Day AS; Leach ST; Lemberg DA
    Expert Rev Mol Diagn; 2017 Sep; 17(9):835-843. PubMed ID: 28770636
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Biomarkers in inflammatory bowel diseases].
    Roblin X; Cavaille A; Clavel L; Paul S
    Presse Med; 2014 Jan; 43(1):66-73. PubMed ID: 24373717
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A novel pathogenesis of inflammatory bowel disease from the perspective of glyco-immunology.
    Shinzaki S; Iijima H; Fujii H; Kamada Y; Naka T; Takehara T; Miyoshi E
    J Biochem; 2017 May; 161(5):409-415. PubMed ID: 28338836
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The IBD SGI Diagnostic Test Is Frequently Used by Non-gastroenterologists to Screen for Inflammatory Bowel Disease.
    Berinstein JA; Waljee AK; Stidham RW; Higgins PDR; Govani SM
    Inflamm Bowel Dis; 2018 Apr; 24(5):e18. PubMed ID: 29688480
    [No Abstract]   [Full Text] [Related]  

  • 59. Serologic tests are not helpful in managing inflammatory bowel disease.
    Present DH
    Inflamm Bowel Dis; 2002 May; 8(3):227-9; discussion 223, 230-1. PubMed ID: 11979147
    [No Abstract]   [Full Text] [Related]  

  • 60. Is urotensin II a new inflammatory marker of inflammatory bowel disease?
    Vernero M
    Minerva Gastroenterol Dietol; 2019 Sep; 65(3):173-174. PubMed ID: 31347342
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.